Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry

被引:249
作者
Zuo, Feng
Nakamura, Norio
Akao, Teruaki
Hattori, Masao
机构
[1] Toyama Univ, Inst Nat Med, Dept Metab Engn, Toyama 9300194, Japan
[2] Toyama Univ, Fac Pharmaceut Sci, Toyama 9300194, Japan
关键词
D O I
10.1124/dmd.106.011361
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Berberine (Ber) and its main metabolites were identified and quantified using liquid chromatography/electrospray ionization/ion trap mass spectrometry. Rat plasma contained the main metabolites, berberrubine, thalifendine, demethyleneberberine, and jatrorrhizine, as free and glucuronide conjugates after p.o. Ber administration. Moreover, the original drug, the four main metabolites, and their glucuronide conjugates were all detected in liver tissues after 0.5 h and in bile samples 1 h after p.o. Ber administration. Therefore, the metabolic site seemed to be the liver, and the metabolites and conjugates were evidently excreted into the duodenum as bile. The pharmacokinetics of Ber and the four metabolites were determined in conventional and pseudo germ-free rats ( treated with antibiotics) after p.o. administration with 40 mg/kg Ber. The AUC(0-limt) and mean transit time values of the metabolites significantly differed between conventional and pseudo germ-free rats. The amounts of metabolites were remarkably reduced in the pseudo germ-free rats, whereas levels of Ber did not obviously differ between the two groups. The intestinal flora did not exert significant metabolic activity against Ber and its metabolites, but it played a significant role in the enterohepatic circulation of metabolites. In this sense, the liver and intestinal bacteria participate in the metabolism and disposition of Ber in vivo.
引用
收藏
页码:2064 / 2072
页数:9
相关论文
共 40 条
[1]   Balicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form [J].
Akao, T ;
Kawabata, K ;
Yanagisawa, E ;
Ishihara, K ;
Mizuhara, Y ;
Wakui, Y ;
Sakashita, Y ;
Kobashi, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (12) :1563-1568
[2]   Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children [J].
Bouwmeester, NJ ;
Anderson, BJ ;
Tibboel, D ;
Holford, NHG .
BRITISH JOURNAL OF ANAESTHESIA, 2004, 92 (02) :208-217
[3]   Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium [J].
Čerňáková M. ;
Košt'álová D. ;
Kettmann V. ;
Plodová M. ;
Tóth J. ;
Dřímal J. .
BMC Complementary and Alternative Medicine, 2 (1)
[4]   DETERMINATION OF BERBERINE IN PLASMA, URINE AND BILE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
CHEN, CM ;
CHANG, HC .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 665 (01) :117-123
[5]   Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, 2-ethyl-5-methyl-3,3-diphenylpyraline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry [J].
Choo, RE ;
Murphy, CM ;
Jones, HE ;
Huestis, MA .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 814 (02) :369-373
[6]   Conversion of berberine into berberrubine by selective demethylation under microwave irradiation [J].
Das, B ;
Srinivas, KVNS .
SYNTHETIC COMMUNICATIONS, 2002, 32 (19) :3027-3029
[7]   ROLE OF THE INTESTINAL MICROFLORA IN CLONAZEPAM METABOLISM IN THE RAT [J].
ELMER, GW ;
REMMEL, RP .
XENOBIOTICA, 1984, 14 (11) :829-840
[8]  
GUDIMA SO, 1994, MOL BIOL+, V28, P809
[9]  
HOSHI A, 1976, GANN, V67, P321
[10]  
Kettmann V, 2004, PHARMAZIE, V59, P548